{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:15:55Z","timestamp":1791152155969,"version":"4.1.0"},"reference-count":65,"publisher":"Impact Journals, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,2,20]]},"DOI":"10.18632\/oncotarget.2218","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T08:00:44Z","timestamp":1442304044000},"page":"2754-2766","source":"Crossref","is-referenced-by-count":114,"title":["Mutational spectrum of adult T-ALL"],"prefix":"10.18632","volume":"6","author":[{"given":"Martin","family":"Neumann","sequence":"first","affiliation":[{"name":"Charit\u00e9, Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Vosberg","sequence":"additional","affiliation":[{"name":"Clinical Cooperative Group \u2018Leukemia\u2019, Helmholtz Zentrum M\u00fcnchen, German Research Center for Environmental Health, Munich, Germany"},{"name":"Department of Internal Medicine 3, Ludwig-Maximilians-Universit\u00e4t (LMU), Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Schlee","sequence":"additional","affiliation":[{"name":"Charit\u00e9, Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Heesch","sequence":"additional","affiliation":[{"name":"Charit\u00e9, Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Charit\u00e9, Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"G\u00f6kbuget","sequence":"additional","affiliation":[{"name":"Goethe University Hospital, Department of Medicine II, Hematology\/Oncology, Frankfurt\/M., Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Hoelzer","sequence":"additional","affiliation":[{"name":"Goethe University Hospital, Department of Medicine II, Hematology\/Oncology, Frankfurt\/M., Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Graf","sequence":"additional","affiliation":[{"name":"Laboratory for Functional Genome Analysis, Gene-Center, Ludwig-Maximilians-Universit\u00e4t (LMU), Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Krebs","sequence":"additional","affiliation":[{"name":"Laboratory for Functional Genome Analysis, Gene-Center, Ludwig-Maximilians-Universit\u00e4t (LMU), Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bartram","sequence":"additional","affiliation":[{"name":"Charit\u00e9, Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Blum","sequence":"additional","affiliation":[{"name":"Laboratory for Functional Genome Analysis, Gene-Center, Ludwig-Maximilians-Universit\u00e4t (LMU), Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Br\u00fcggemann","sequence":"additional","affiliation":[{"name":"University Hospital Kiel, Department of Hematology, University Hospital Schleswig-Holstein, Campus Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Hecht","sequence":"additional","affiliation":[{"name":"Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"Bohlander","sequence":"additional","affiliation":[{"name":"Clinical Cooperative Group \u2018Leukemia\u2019, Helmholtz Zentrum M\u00fcnchen, German Research Center for Environmental Health, Munich, Germany"},{"name":"Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp A.","family":"Greif","sequence":"additional","affiliation":[{"name":"Clinical Cooperative Group \u2018Leukemia\u2019, Helmholtz Zentrum M\u00fcnchen, German Research Center for Environmental Health, Munich, Germany"},{"name":"Department of Internal Medicine 3, Ludwig-Maximilians-Universit\u00e4t (LMU), Munich, Germany"},{"name":"German Cancer Consortium (DKTK), Heidelberg, Germany"},{"name":"German Cancer Research Centre (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia D.","family":"Baldus","sequence":"additional","affiliation":[{"name":"Charit\u00e9, Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany"},{"name":"German Cancer Consortium (DKTK), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2014,7,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.seminhematol.2008.09.003","article-title":"Treatment of adult acute lymphoblastic leukemia","volume":"46","author":"Hoelzer","year":"2009","journal-title":"Semin. Hematol."},{"issue":"Suppl 1","key":"2","first-page":"S129","article-title":"Risk\/MRD adapted GMALL trials in adult ALL","volume":"83","author":"Hoelzer","year":"2004","journal-title":"Ann. Hematol."},{"key":"3","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","article-title":"T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993)","volume":"114","author":"Tallman","year":"2009","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1200\/JCO.2009.26.9456","article-title":"Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia","volume":"28","author":"Kantarjian","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"5","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1182\/blood-2012-07-441030","article-title":"Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL","volume":"120","author":"Burmeister","year":"2012","journal-title":"Blood"},{"key":"6","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/cncr.22631","article-title":"Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)","volume":"109","author":"Hoelzer","year":"2007","journal-title":"Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1182\/blood-2011-01-329441","article-title":"High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia\/lymphoma offers curative option with subsequent stem cell transplantation","volume":"118","author":"Stelljes","year":"2011","journal-title":"Blood"},{"key":"8","first-page":"1","article-title":"The biology of T-cell acute lymphoblastic leukemia","volume":"2013","author":"Cools","year":"2013","journal-title":"Hematology Education:the Education Program for Theannual Congress of the EuropeanHematology Association"},{"key":"9","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/leu.2009.18","article-title":"Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions","volume":"23","author":"Downing","year":"2009","journal-title":"Leukemia"},{"key":"10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Aster","year":"2004","journal-title":"Science"},{"key":"11","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood-2005-12-4956","article-title":"Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia","volume":"108","author":"Kulozik","year":"2006","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/leu.2010.237","article-title":"NOTCH mutations as prognostic markers in T-ALL","volume":"24","author":"Ferrando","year":"2010","journal-title":"Leukemia"},{"key":"13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3324\/haematol.2008.005272","article-title":"Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia","volume":"94","author":"Hofmann","year":"2009","journal-title":"Haematologica"},{"key":"14","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1182\/blood-2008-10-184069","article-title":"NOTCH1\/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study","volume":"113","author":"Bene","year":"2009","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4161\/cc.7.8.5753","article-title":"The role of the PTEN\/AKT Pathway in NOTCH1-induced leukemia","volume":"7","author":"Ferrando","year":"2008","journal-title":"Cell Cycle"},{"key":"16","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/leu.2010.204","article-title":"NOTCH1 and\/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols","volume":"24","author":"Meijerink","year":"2010","journal-title":"Leukemia"},{"key":"17","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3324\/haematol.2009.016386","article-title":"Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia","volume":"95","author":"Baldus","year":"2010","journal-title":"Haematologica"},{"key":"18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/leu.2009.209","article-title":"Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia","volume":"24","author":"Yunes","year":"2010","journal-title":"Leukemia"},{"key":"19","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1182\/blood-2010-11-318873","article-title":"The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia","volume":"118","author":"Alt","year":"2011","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/gcc.22039","article-title":"The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL","volume":"52","author":"Kohlmann","year":"2013","journal-title":"Genes Chromosomes. Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Roberts","year":"2012","journal-title":"Nature"},{"key":"22","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","article-title":"Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations","volume":"121","author":"Hecht","year":"2013","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.20110580","article-title":"Gain-of-function mutations in interleukin-7 receptor-alpha (IL7R) in childhood acute lymphoblastic leukemias","volume":"208","author":"Izraeli","year":"2011","journal-title":"J. Exp. Med."},{"key":"24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20072182","article-title":"Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia","volume":"205","author":"Cazzaniga","year":"2008","journal-title":"J. Exp. Med."},{"key":"25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ng.2508","article-title":"Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia","volume":"45","author":"Vandepoel","year":"2013","journal-title":"Nat. Genet."},{"key":"26","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1182\/blood-2008-12-192039","article-title":"WT1 mutations in T-ALL","volume":"114","author":"Rowe","year":"2009","journal-title":"Blood"},{"key":"27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.542","article-title":"PHF6 mutations in T-cell acute lymphoblastic leukemia","volume":"42","author":"Pisecker","year":"2010","journal-title":"Nat. Genet."},{"key":"28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","article-title":"Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia","volume":"19","author":"Horstmann","year":"2011","journal-title":"Cancer Cell"},{"key":"29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3324\/haematol.2013.090233","article-title":"Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors","volume":"99","author":"Meijerink","year":"2014","journal-title":"Haematologica"},{"key":"30","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1182\/blood-2009-07-234377","article-title":"Inactivation of LEF1 in T-cell acute lymphoblastic leukemia","volume":"115","author":"Sallan","year":"2010","journal-title":"Blood"},{"key":"31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Getz","year":"2014","journal-title":"Nature"},{"key":"32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Look","year":"2002","journal-title":"Cancer Cell"},{"key":"33","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T cell acute lymphoblastic leukemia","volume":"122","author":"Ferrando","year":"2012","journal-title":"J. Clin. Invest."},{"key":"34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.beha.2010.08.002","article-title":"Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia","volume":"23","author":"Meijerink","year":"2010","journal-title":"Best. Pract. Res. Clin. Haematol."},{"key":"35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.coi.2011.12.012","article-title":"Transcriptional drivers of the T-cell lineage program","volume":"24","author":"Rothenberg","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Campana","year":"2009","journal-title":"Lancet Oncol"},{"key":"37","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1038\/bcj.2011.49","article-title":"Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations","volume":"2","author":"Baldus","year":"2012","journal-title":"Blood Cancer J."},{"key":"38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MOH.0b013e3283623c61","article-title":"Early T-cell precursor acute lymphoblastic leukaemia","volume":"20","author":"Ferrando","year":"2013","journal-title":"Curr. Opin. Hematol."},{"key":"39","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20070876","article-title":"FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors","volume":"204","author":"Look","year":"2007","journal-title":"J. Exp. Med."},{"key":"40","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1084\/jem.20070872","article-title":"The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia","volume":"204","author":"Aifantis","year":"2007","journal-title":"J. Exp. Med."},{"key":"41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Li","year":"2011","journal-title":"Nature"},{"key":"42","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","author":"Puente","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"43","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Gould","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2010-07-298349","article-title":"The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells","volume":"117","author":"Licht","year":"2011","journal-title":"Blood"},{"key":"45","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/ng.2777","article-title":"Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia","volume":"45","author":"Easton","year":"2013","journal-title":"Nat. Genet."},{"key":"46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/leu.2013.204","article-title":"Point mutation E1099K in MMSET\/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies","volume":"28","author":"Popovic","year":"2014","journal-title":"Leukemia"},{"key":"47","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/leu.2013.58","article-title":"Clonal diversity of recurrently mutated genes in myelodysplastic syndromes","volume":"27","author":"Link","year":"2013","journal-title":"Leukemia"},{"key":"48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.2538","article-title":"Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation","volume":"45","author":"Singh","year":"2013","journal-title":"Nat. Genet."},{"key":"49","article-title":"Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness","author":"Pasqualucci","year":"2014","journal-title":"Blood"},{"key":"50","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/ajmg.a.36072","article-title":"MLL2 and KDM6A mutations in patients with Kabuki syndrome","volume":"161","author":"Shotelersuk","year":"2013","journal-title":"Am. J. Med. Genet. A."},{"key":"51","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tig.2005.01.008","article-title":"The etiology of Wolf-Hirschhorn syndrome","volume":"21","author":"Hirschhorn","year":"2005","journal-title":"Trends Genet."},{"key":"52","unstructured":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 2013; 368:2059\u20132074."},{"key":"53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Otsu","year":"2011","journal-title":"Nature"},{"key":"54","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","volume":"44","author":"Melnick","year":"2012","journal-title":"Nat. Genet."},{"key":"55","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2009.07912.x","article-title":"JAK1 mutations are not frequent events in adult T-ALL: a GRAALL study","volume":"148","author":"MacIntyre","year":"2010","journal-title":"Br. J. Haematol"},{"key":"56","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"Constantinescu","year":"2013","journal-title":"Oncogene"},{"key":"57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Chen","year":"2012","journal-title":"Cell"},{"key":"58","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1073\/pnas.1213968110","article-title":"Impact of deleterious passenger mutations on cancer progression","volume":"110","author":"Mirny","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"59","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Ramos","year":"2013","journal-title":"Nature"},{"key":"60","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ng.2558","article-title":"Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia","volume":"45","author":"Morrison","year":"2013","journal-title":"Nat. Genet."},{"key":"61","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.3078","article-title":"Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL","volume":"19","author":"Rabadan","year":"2013","journal-title":"Nat. Med."},{"key":"62","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.leu.2402989","article-title":"Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(\u2212)\/CD24(\u2212)\/CD65s(+)\/CD15(+) B-cell phenotype","volume":"17","author":"Thiel","year":"2003","journal-title":"Leukemia"},{"key":"63","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Van't Veer","year":"1995","journal-title":"Leukemia"},{"key":"64","doi-asserted-by":"crossref","first-page":"e53190","DOI":"10.1371\/journal.pone.0053190","article-title":"FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors","volume":"8","author":"Ehninger","year":"2013","journal-title":"PLoS. One"},{"key":"65","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/ng.2731","article-title":"Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms","volume":"45","author":"Nowak","year":"2013","journal-title":"Nat. Genet."}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T09:41:11Z","timestamp":1589362871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,15]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,2,20]]}},"alternative-id":["2218","25595890"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.2218","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,15]]}}}